Treatment for Stage I Bladder Cancer
Stage I transitional cell carcinoma (TCC) of the urinary bladder is defined as cancer that has invaded the submucosa but not the deeper muscle layer of the bladder wall.
The recommended initial treatment for non-invasive bladder tumors, including Stage I (confined to mucosa and submucosa), is typically Trans urethral resection of bladder tumour (TURBT).
Why TURBT is Recommended
- TURBT is a minimally invasive procedure performed using a resectoscope inserted through the urethra.
- It allows for the complete removal or destruction of the tumor while obtaining tissue for accurate staging and grading.
- For tumors limited to the mucosa and submucosa (Stage I), TURBT is often curative and avoids the morbidity associated with more extensive surgeries.
Other Treatment Options Considered
- Radical cystectomy: This involves removing the entire bladder and is generally reserved for muscle-invasive bladder cancer (Stage II or higher) or high-risk non-muscle-invasive disease that has recurred after adequate TURBT.
- Radiation therapy: While sometimes used in combination with chemotherapy or for patients unsuitable for surgery, it's not the primary treatment for early-stage, non-invasive TCC.
- Systemic chemotherapy: This is typically used for advanced or metastatic bladder cancer, or sometimes intravesically after TURBT for high-risk non-muscle-invasive disease, but not as the primary treatment for Stage I TCC itself.
Therefore, TURBT is the standard and most appropriate treatment for Stage I bladder cancer.